|
|
|
By Kevin Blighe, Ph.D. | Think global trial supply is just FDA compliance? Customs rules, local sourcing mandates, climate shocks, and regulations complicate planning, disrupt timelines, and reshape how clinical supply chains operate. | |
|
|
|
By Joseph G. Oberlander, Ph.D. | CNS trials demand precision supply chains. From DTP logistics to dynamic forecasting, small disruptions can compromise data, adherence, and outcomes. | |
|
|
|
By Irena Maksimovic, Ph.D., Bristol Myers Squibb | Digital tools won’t fix broken clinical supply processes. Real transformation starts with smarter protocol design, sourcing strategy, planning alignment, and decision governance. | |
|
|
|
|
|
|
|
.png){kind=logo}
